The Latest Breaking News from Omicron

CH.1.1 is an Omicron with a concerning Delta mutation—not quite a "Deltacron," but still potentially concerning, experts say.

LOS ANGELES — Three years to the day after reporting its first confirmed case of COVID-19, Los Angeles County is “in a much better place” in the pandemic — hard-won progress a top health official attributed to vaccination, community immunity resulting from the virus’ rampant spread and development of tools…

Most common symptoms revealed as UKHSA warns Covid is currently ‘circulating at high levels’

The aim of Thursday’s meeting was to “determine if we’ve reached a point in the pandemic where we can simplify and take a more routine approach,” said Dr. David Kaslow, director of the Office of Vaccines Research and Review at the FDA.

‘Emergency’ surge vaccines could also be required if a new variant arises that is different to Omicron

The updated COVID-19 boosters from Pfizer Inc/BioNTech SE and Moderna helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines perform against these fast-spreading strains, U.S. officials said on Wednesday.

By almost any measure, the vaccination campaign against SARS-CoV-2, the virus that causes COVID-19, has been a global success.

LOS ANGELES — In the first two years of the COVID-19 pandemic, winter holidays were marred by a pair of devastating waves that ripped through California, sending case counts soaring, residents to the hospital in droves and, ultimately, leaving thousands dead.

Noel Pearson suggests opposition leader Peter Dutton is playing ‘a spoiling game’ as experts say detail on voice comes later

A Pfizer booster that specifically tackles two Omicron COVID-19 variants has been given provisional approval by the Therapeutic Goods Administration.

XBB.1.5 is the most genetically rich and transmissible SARS-CoV-2 Omicron subvariant yet detected in the United States, Europe, and other places.